about
Impella ventricular support in clinical practice: Collaborative viewpoint from a European expert user groupSafety and efficacy of digoxin: systematic review and meta-analysis of observational and controlled trial dataEcstasy induced acute myocardial infarctionEffects of coronary revascularisation on myocardial blood flow and coronary vasodilator reserve in hibernating myocardiumSpironolactone to prevent cardiovascular events in early-stage chronic kidney disease (STOP-CKD): study protocol for a randomized controlled pilot trial.Phosphate: are we squandering a scarce commodity?Diffuse endothelial dysfunction is common to ANCA associated systemic vasculitis and polyarteritis nodosaEstimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data.Detection of myocardial infarction by immunohistological staining for C9 on formalin fixed, paraffin wax embedded sections.Benefits of Aldosterone Receptor Antagonism in Chronic Kidney Disease (BARACK D) trial-a multi-centre, prospective, randomised, open, blinded end-point, 36-month study of 2,616 patients within primary care with stage 3b chronic kidney disease to comPrediction of ESRD and death among people with CKD: the Chronic Renal Impairment in Birmingham (CRIB) prospective cohort studyACE inhibition in aortic stenosis: dangerous medicine or golden opportunity?Cytomegalovirus seropositivity is associated with increased arterial stiffness in patients with chronic kidney disease.Heart rate variability--a therapeutic target?Mortality, cardiac vagal control and physical training--what's the link?Endothelial nitric oxide synthase single nucleotide polymorphism and left ventricular function in early chronic kidney disease.Predictive value of dobutamine echocardiography and positron emission tomography in identifying hibernating myocardium in patients with postischaemic heart failure.Coronary revascularisation for postischaemic heart failure: how myocardial viability affects survival.Incremental shuttle walk test in the assessment of patients for heart transplantation.Perinatal and maternal outcomes in planned home and obstetric unit births in women at 'higher risk' of complications: secondary analysis of the Birthplace national prospective cohort study.Acute Care QUAliTy in chronic Kidney disease (ACQUATIK): a prospective cohort study exploring outcomes of patients with chronic kidney disease.Serum free light chains and the risk of ESRD and death in CKDPercutaneous Mechanical Ventricular Support in Acute Cardiac Care: A UK Quaternary Centre Experience Using 2.5L, 3.8L and 5.0L Impella CathetersTraceless Production of Cyclic Peptide Libraries in E. coli.The safety and tolerability of spironolactone in patients with mild to moderate chronic kidney disease.Development of an international scale of socio-economic position based on household assetsEffect of mineralocorticoid receptor antagonists on proteinuria and progression of chronic kidney disease: a systematic review and meta-analysisVariability in cardiac MR measurement of left ventricular ejection fraction, volumes and mass in healthy adults: defining a significant change at 1 year.Spontaneous Coronary Artery Dissection/Intramural Haematoma in Young Women with ST-Elevation Myocardial Infarction: "It Is Not Always a Plaque Rupture Event".Mechanical effects of left ventricular midwall fibrosis in non-ischemic cardiomyopathy.Cardiovascular Effects of Unilateral Nephrectomy in Living Kidney Donors.Results and lessons from the Spironolactone To Prevent Cardiovascular Events in Early Stage Chronic Kidney Disease (STOP-CKD) randomised controlled trial.Cardiovascular effects of sevelamer in stage 3 CKD.Prognostic Utility of Calcium Scoring as an Adjunct to Stress Myocardial Perfusion Scintigraphy in End-Stage Renal DiseasePeripheral haemodynamic effects of inhibition of prostaglandin synthesis in congestive heart failure and interactions with captopril.Effect of A Reduction in glomerular filtration rate after NEphrectomy on arterial STiffness and central hemodynamics: rationale and design of the EARNEST study.Republished paper: Arterial stiffness in chronic kidney disease: causes and consequences.Arterial disease in chronic kidney disease.Central blood pressure in chronic kidney disease: latest evidence and clinical relevance.Cardiovascular actions of mineralocorticoid receptor antagonists in patients with chronic kidney disease: A systematic review and meta-analysis of randomized trials.
P50
Q26781346-65D4F5ED-9130-4167-AD12-43B0467F30AAQ26796271-E00F7E0C-BA12-4297-A353-566E74906ADFQ28183846-EB8F5DF7-36F0-49E1-8DB7-295643103E4CQ28345981-5CD2ABD1-0936-459D-B2DB-D8833605FE6AQ30585060-6D5601F1-E497-43BB-8F04-D91D76C8F754Q30852623-765A4F1A-C217-4C01-B3E5-89316E16726DQ30881300-33F29900-455E-444E-ADFA-EB8D173119A5Q30961976-49D0A652-1211-47E3-B145-505C0D9058EAQ33608902-7C254EEB-2E51-4355-8E67-D92B5A1FA090Q33960590-C4C68113-675E-46AF-A9BC-E114AA30BDBCQ34349235-6645361E-A7D9-44B8-9509-52D22DBDE819Q34405412-CC66814D-D9D2-415E-AD40-78DF446DAB71Q34602254-B10D8882-8DD1-4469-B4BC-D10284D207B2Q34613889-85E1A7FD-8D23-4BC3-995A-8F225233CAE3Q34976678-B4C4F2BC-288A-4DD3-A4A8-CEC9AA50AC74Q35001614-E29AE7F0-E2D3-4ACB-A20E-690FD022D45BQ35366928-EAC0E4A6-BFCE-45D9-B9D2-303AE31B3BC8Q35374110-EBD52525-4994-45BE-95EE-1B2BEE4F7612Q35380397-F3DCC621-EE19-44B7-84FA-30283EE5F241Q35538332-F9FCCDD5-1118-41F7-B77C-DBCE28EC1394Q35573137-09404505-B1C3-41B5-9E30-8F75D626CC06Q35664565-7B227F79-9A05-4249-8158-29ED466A6E13Q35756621-458134D5-F29B-47B2-9F85-BE05F57D2955Q35973607-E328FC82-E857-48A5-9971-FA590E24D362Q36017400-5D82712A-FA00-4C45-B1DC-B5A201C49645Q36081949-E183DBB1-E496-4DC1-9B87-4662EC11BE64Q36127484-25A5526A-A36A-4709-AA7C-DFE7017AC527Q36235555-BE424C0A-3E66-47E0-BA62-4B15CFA4AE3BQ36245360-B1957545-486B-4E69-81EC-058B2EEDDBB7Q36428548-6BF34949-A2C4-4CCF-AD8D-42F1D9BE6CB6Q36472396-35068291-1967-4EDA-848F-EAF9D7E0C3FCQ36625246-43661948-5800-4844-8615-C5AB3341FB9FQ36796599-6C86CE9D-4DB9-49FD-B7F7-B2566482E707Q36814442-7990E39A-C5EE-4F27-8954-831BB5A5EC8BQ36818647-9F9F90CC-936D-4025-A6A5-B361F2F9F1C3Q37522761-C83A867F-3C54-4C81-ABFB-A81981E11E26Q37788873-88F6A141-2568-43E2-9C6D-A69708D0A753Q38057189-358DD44C-A05D-4FA9-9683-3CDBFE0665EAQ38304070-DBCBE6E5-F380-4AB6-9B4F-0AAA48B9B5DBQ38382456-43571F02-FC99-42DD-8677-4F38955AD162
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Jonathan N Townend
@ast
Jonathan N Townend
@en
Jonathan N Townend
@es
Jonathan N Townend
@nl
Jonathan N Townend
@sl
type
label
Jonathan N Townend
@ast
Jonathan N Townend
@en
Jonathan N Townend
@es
Jonathan N Townend
@nl
Jonathan N Townend
@sl
altLabel
Jonathan Townend
@en
prefLabel
Jonathan N Townend
@ast
Jonathan N Townend
@en
Jonathan N Townend
@es
Jonathan N Townend
@nl
Jonathan N Townend
@sl
P106
P21
P31
P496
0000-0002-5881-5806